Polycystic Ovary Syndrome (PCOS) Drugs Market Report

Global and Region Polycystic Ovary Syndrome (PCOS) Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：147
  • REPORT CODE：GMM883626
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Polycystic Ovary Syndrome (PCOS) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Polycystic Ovary Syndrome (PCOS) Drugsmarket, defines the market attractiveness level of Polycystic Ovary Syndrome (PCOS) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Polycystic Ovary Syndrome (PCOS) Drugs industry, describes the types of Polycystic Ovary Syndrome (PCOS) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Polycystic Ovary Syndrome (PCOS) Drugs market and the development prospects and opportunities of Polycystic Ovary Syndrome (PCOS) Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Polycystic Ovary Syndrome (PCOS) Drugs market in Chapter 13.

    By Player:

    • Sanofi

    • AstraZeneca plc

    • Merck KGaA

    • BIOCAD

    • Ferring Pharmaceuticals Inc

    • Teva Pharmaceutical Industries Limited

    • Novartis AG

    • Crinetics Pharmaceuticals Inc

    • Bristol Myers Squibb Co

    • Addex Therapeutics Ltd

    By Type:

    • Oral Contraceptives

    • Antiandrogens

    • Insulin-sensitizing Agent

    • Antidepressant

    • Anti-obesity

    By End-User:

    • Hospital

    • Clinic

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Polycystic Ovary Syndrome (PCOS) Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Polycystic Ovary Syndrome (PCOS) Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Polycystic Ovary Syndrome (PCOS) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Polycystic Ovary Syndrome (PCOS) Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2017-2022)

    • 7.2 United States Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2017-2022)

    • 7.3 Europe Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2017-2022)

    • 7.4 China Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2017-2022)

    • 7.5 Japan Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2017-2022)

    • 7.6 India Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2017-2022)

    • 7.7 South Korea Polycystic Ovary Syndrome (PCOS) Drugs Consumption (2017-2022)

    8 Region and Country-wise Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2022-2028)

    • 8.4 China Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2022-2028)

    • 8.6 India Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast (2022-2028)

    9 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Contraceptives Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antiandrogens Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Insulin-sensitizing Agent Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Antidepressant Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Anti-obesity Consumption and Growth Rate (2017-2022)

    • 9.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

    10 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Contraceptives Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Antiandrogens Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Insulin-sensitizing Agent Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Antidepressant Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Anti-obesity Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    11 Global Polycystic Ovary Syndrome (PCOS) Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Polycystic Ovary Syndrome (PCOS) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Competitive Analysis

    • 14.1 Sanofi

      • 14.1.1 Sanofi Company Details

      • 14.1.2 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.2 AstraZeneca plc

      • 14.2.1 AstraZeneca plc Company Details

      • 14.2.2 AstraZeneca plc Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca plc Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.3 Merck KGaA

      • 14.3.1 Merck KGaA Company Details

      • 14.3.2 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.4 BIOCAD

      • 14.4.1 BIOCAD Company Details

      • 14.4.2 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.5 Ferring Pharmaceuticals Inc

      • 14.5.1 Ferring Pharmaceuticals Inc Company Details

      • 14.5.2 Ferring Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ferring Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.6 Teva Pharmaceutical Industries Limited

      • 14.6.1 Teva Pharmaceutical Industries Limited Company Details

      • 14.6.2 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.7 Novartis AG

      • 14.7.1 Novartis AG Company Details

      • 14.7.2 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.8 Crinetics Pharmaceuticals Inc

      • 14.8.1 Crinetics Pharmaceuticals Inc Company Details

      • 14.8.2 Crinetics Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Crinetics Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.9 Bristol Myers Squibb Co

      • 14.9.1 Bristol Myers Squibb Co Company Details

      • 14.9.2 Bristol Myers Squibb Co Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol Myers Squibb Co Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • 14.10 Addex Therapeutics Ltd

      • 14.10.1 Addex Therapeutics Ltd Company Details

      • 14.10.2 Addex Therapeutics Ltd Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Addex Therapeutics Ltd Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Polycystic Ovary Syndrome (PCOS) Drugs

    • Figure Polycystic Ovary Syndrome (PCOS) Drugs Picture

    • Table Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Country (2017-2022)

    • Figure United States Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Polycystic Ovary Syndrome (PCOS) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Polycystic Ovary Syndrome (PCOS) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Contraceptives Consumption and Growth Rate (2017-2022)

    • Figure Global Antiandrogens Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin-sensitizing Agent Consumption and Growth Rate (2017-2022)

    • Figure Global Antidepressant Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-obesity Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Contraceptives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antiandrogens Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin-sensitizing Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antidepressant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-obesity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Polycystic Ovary Syndrome (PCOS) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Polycystic Ovary Syndrome (PCOS) Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table AstraZeneca plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca plc Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table BIOCAD (Foundation Year, Company Profile and etc.)

    • Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table Ferring Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Ferring Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table Teva Pharmaceutical Industries Limited (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table Crinetics Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Crinetics Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Crinetics Pharmaceuticals Inc Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table Bristol Myers Squibb Co (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Co Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Co Polycystic Ovary Syndrome (PCOS) Drugs Product and Service

    • Table Addex Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Addex Therapeutics Ltd Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Addex Therapeutics Ltd Polycystic Ovary Syndrome (PCOS) Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US